BRIEF-China Resources Pharmaceutical Receives Notice Of Registration Approval Issued By China Securities Regulatory Commission

Reuters

Jan 27

BRIEF-China Resources Pharmaceutical Receives Notice Of Registration Approval Issued By <a href="https://laohu8.com/S/601066">China Securities</a> Regulatory Commission

Jan 26 (Reuters) - China Resources Pharmaceutical Group Ltd 3320.HK:

RECEIVED NOTICE OF REGISTRATION APPROVAL ISSUED BY CHINA SECURITIES REGULATORY COMMISSION
NOTICE FOR PROPOSED ISSUANCE OF CORPORATE BONDS BY CR DOUBLE-CRANE TO QUALIFIED INVESTORS IN CHINA
CR DOUBLE-CRANE MAY ISSUE BONDS TOTALING RMB3 BILLION

Further company coverage: 3320.HK

((Reuters.Briefs@thomsonreuters.com;))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2606242420"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2606242420\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2606242420?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-27 01:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2606242420","market":"fut","top_or_hot":-1,"title":"BRIEF-China Resources Pharmaceutical Receives Notice Of Registration Approval Issued By China Securities Regulatory Commission","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-China Resources Pharmaceutical Receives Notice Of Registration Approval Issued By <a href=\"https://laohu8.com/S/601066\">China Securities</a> Regulatory Commission</title></head><body><p><span>Jan 26 (Reuters)</span><span> - </span>China Resources Pharmaceutical Group Ltd <span>3320.HK</span>:</p><ul><li><p>RECEIVED NOTICE OF REGISTRATION APPROVAL ISSUED BY CHINA SECURITIES REGULATORY COMMISSION</p></li><li><p>NOTICE FOR PROPOSED ISSUANCE OF CORPORATE BONDS BY CR DOUBLE-CRANE TO QUALIFIED INVESTORS IN CHINA</p></li><li><p>CR DOUBLE-CRANE MAY ISSUE BONDS TOTALING RMB3 BILLION</p></li></ul><p>Further company coverage: <span>3320.HK</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-China Resources Pharmaceutical Receives Notice Of Registration Approval Issued By China Securities Regulatory Commission</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-China Resources Pharmaceutical Receives Notice Of Registration Approval Issued By China Securities Regulatory Commission\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-01-27 01:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-China Resources Pharmaceutical Receives Notice Of Registration Approval Issued By <a href=\"https://laohu8.com/S/601066\">China Securities</a> Regulatory Commission</title></head><body><p><span>Jan 26 (Reuters)</span><span> - </span>China Resources Pharmaceutical Group Ltd <span>3320.HK</span>:</p><ul><li><p>RECEIVED NOTICE OF REGISTRATION APPROVAL ISSUED BY CHINA SECURITIES REGULATORY COMMISSION</p></li><li><p>NOTICE FOR PROPOSED ISSUANCE OF CORPORATE BONDS BY CR DOUBLE-CRANE TO QUALIFIED INVESTORS IN CHINA</p></li><li><p>CR DOUBLE-CRANE MAY ISSUE BONDS TOTALING RMB3 BILLION</p></li></ul><p>Further company coverage: <span>3320.HK</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03320","symbol_name":"华润医药","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nFWN3YP07U:1","article_id":"2606242420","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2606242420","pubTimestamp":1769446801,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-China Resources Pharmaceutical Receives Notice Of Registration Approval Issued By China Securities Regulatory CommissionJan 26  - China Resources Pharmaceutical Group Ltd 3320.HK:RECEIVED NOTICE OF REGISTRATION APPROVAL ISSUED BY CHINA SECURITIES REGULATORY COMMISSIONNOTICE FOR PROPOSED ISSUANCE OF CORPORATE BONDS BY CR DOUBLE-CRANE TO QUALIFIED INVESTORS IN CHINACR DOUBLE-CRANE MAY ISSUE BONDS TOTALING RMB3 BILLIONFurther company coverage: 3320.HK ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03320":"华润医药","BK1570":"华润系","BK1191":"制药"},"translate_title":"简报-华润医药收到证监会核准注册通知书","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03320":0.9},"content_text":"BRIEF-China Resources Pharmaceutical Receives Notice Of Registration Approval Issued By China Securities Regulatory CommissionJan 26 (Reuters) - China Resources Pharmaceutical Group Ltd 3320.HK:RECEIVED NOTICE OF REGISTRATION APPROVAL ISSUED BY CHINA SECURITIES REGULATORY COMMISSIONNOTICE FOR PROPOSED ISSUANCE OF CORPORATE BONDS BY CR DOUBLE-CRANE TO QUALIFIED INVESTORS IN CHINACR DOUBLE-CRANE MAY ISSUE BONDS TOTALING RMB3 BILLIONFurther company coverage: 3320.HK ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"policyRegulatory","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":true,"code":"91000000","status":"200"}}}